Alkermes Ownership | Who Owns Alkermes?
Alkermes Ownership Summary
Alkermes is owned by 108.34% institutional investors, 1.41% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 17.59% of ALKS shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.05% of its assets in Alkermes shares.
ALKS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alkermes | 108.34% | 1.41% | -9.74% |
| Sector | Healthcare Stocks | 50.62% | 12.41% | 36.97% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 35.37% | 14.85% | 49.78% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 29.24M | 17.59% | $1.53B |
| Blackrock | 29.11M | 17.33% | $701.49M |
| Vanguard group | 18.01M | 10.91% | $503.85M |
| Baker bros. advisors lp | 10.01M | 6.02% | $524.59M |
| State street | 9.16M | 5.51% | $479.97M |
| Vanguard capital management | 7.52M | 4.52% | $393.75M |
| Price t rowe associates inc /md/ | 6.74M | 4.05% | $353.00M |
| Renaissance | 6.46M | 3.89% | $338.52M |
| Geode capital management | 4.48M | 2.69% | $234.66M |
| Dimensional fund advisors lp | 4.19M | 2.52% | $219.79M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Commodore capital lp | 3.00M | 9.36% | $157.19M |
| Bain capital life sciences investors | 1.94M | 6.04% | $101.54M |
| Artia global partners lp | 448.96K | 4.34% | $23.52M |
| Prosight management, lp | 394.39K | 3.56% | $20.66M |
| Knott david m jr | 121.76K | 3.37% | $6.38M |
| Deep track capital, lp | 4.00M | 3.05% | $209.58M |
| Healthinvest partners ab | 213.33K | 3.01% | $11.18M |
| Bvf inc/il | 2.15M | 2.89% | $112.90M |
| Bioimpact capital | 549.26K | 2.70% | $16.48M |
| Affinity asset advisors | 1.13M | 2.66% | $58.94M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sixth street partners management company | 2.34M | 0.02% | 2.34M |
| Norges bank | 2.16M | 0.01% | 2.16M |
| Price t rowe associates inc /md/ | 6.74M | 0.04% | 2.07M |
| Adage capital partners gp | 1.37M | 0.10% | 1.37M |
| Bain capital life sciences investors | 1.94M | 6.04% | 1.33M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | 262.72K | 0.00% | -3.84M |
| Hardman johnston global advisors | - | - | -2.67M |
| American century companies | 3.95M | 0.09% | -2.12M |
| Camber capital management lp | - | - | -1.50M |
| Arrowstreet capital, limited partnership | - | - | -1.45M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 2.34M | 0.02% | 2.34M | $122.35M |
| Norges bank | 2.16M | 0.01% | 2.16M | $113.01M |
| Adage capital partners gp | 1.37M | 0.10% | 1.37M | $71.68M |
| Summit partners public asset management | 950.23K | 0.88% | 950.23K | $49.79M |
| Frontier capital management | 659.56K | 0.32% | 659.56K | $34.56M |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Mather group, llc. | -2.00 |
| Curio wealth | -3.00 |
| Vermillion wealth management | -7.00 |
| Financial synergies wealth advisors | -9.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 434 | 7.96% | 180,048,790 | 2.16% | 108 | 0.95% | 230 | 15.00% | 136 | -8.11% |
| Mar 31, 2026 | 387 | 3.48% | 173,625,031 | -3.72% | 105 | 0.88% | 192 | -4.48% | 143 | 14.40% |
| Dec 31, 2025 | 109 | -70.05% | 28,066,494 | -83.45% | 17 | 0.16% | 61 | -68.88% | 32 | -75.94% |
| Sep 30, 2025 | 135 | -62.60% | 35,434,318 | -79.06% | 21 | 0.20% | 61 | -69.19% | 61 | -48.74% |
| Jun 30, 2025 | 355 | -6.58% | 168,942,978 | -0.75% | 102 | 0.94% | 194 | 3.19% | 118 | -10.61% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 10.15M | 6.05% | -3.92K |
| Vanguard Total Stock Mkt Idx Inv | 5.30M | 3.18% | -4.37K |
| Vanguard US Total Market Shares ETF | 5.16M | 3.17% | -174.71K |
| Vanguard MStar Total Stk Mkt Idx Invest | 5.32M | 3.17% | 16.52K |
| Vanguard Morn Total Stk Mkt Idx Investor | 5.30M | 3.16% | -4.37K |
| Lord Abbett Floating Rate I | 4.68M | 2.81% | 4.68M |
| iShares Russell 2000 ETF | 4.24M | 2.53% | -75.36K |
| Vanguard Small Cap Index | 3.83M | 2.28% | 10.01K |
| Pacer US Small Cap Cash Cows 100 ETF | 2.98M | 1.84% | -21.71K |
| T. Rowe Price U.S. Mid-Cap Val Eq Tr-Z | 2.64M | 1.62% | -69.71K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 01, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $422.87K |
| Aug 17, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | $32.97K |
| Aug 17, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | $339.97K |
| Aug 03, 2026 | snyderman nancy lynn MD | - | Sell | $2.24M |
| Aug 03, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $437.22K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 9 |
| 2026 Q2 | - | 8 |
| 2026 Q1 | - | 11 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | - |
ALKS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools